This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The journal continued to be in good hands, and thus one of the few journals that was receptive to research findings that belied the narrative of therapeutic progress that the psychiatric guild and pharmaceutical companies have been promoting for decades. He noted too the reluctance of the field to consider this possibility.
Before we begin, I’d like to take a few moments and explain the context of this interview. Third, his journal told of the corrupting influence of pharmaceutical money on the creation of psychiatric diagnoses and drug trials. Listen to the audio of the interview here. W elcome to Mad In America Radio.
” This interview was conducted by email. He also sent me to colleagues who had special knowledge of specific areas such as having a control group who did not have the rehab program, as well as scales and schedules to use in interviews, and which statistics to use. We began interviewing in 1980. Appointments were made.
Listen to the audio of the interview here. Then, probably the same year it’s picked up by Eli Lilly, the makers of Prozac, and other pharmaceutical companies who come along with their SSRIs, and they breathe new life into it and recruit this idea, which has already been disproven, to market antidepressants.
Listen to the audio of the interview here. I got into this headspace where I was like, I will not give the pharmaceutical industry one more dollar after what they did to me. The transcript below has been edited for length and clarity. Brooke Siem: Thanks for being here. Who is Dex Carrington, as opposed to Jørgen? It kept me alive.
A seasoned psychiatrist interviewed me, a woman with short, dark, puffy hair and a stern demeanor. She interviewed my mother, striving to understand my history. With samples from a pharmaceutical company eager to gain a new client, Dr. Y also prescribed a benzodiazepine to improve sleep and ease symptoms.
Once again, a pharmaceutical had altered an essential part of my body. Countless supplements and over 30 different pharmaceuticals, I pretty much tried it all. The medical field has become complacent, prioritizing pharmaceutical profits, insurance companies agendas, and established narratives over patients well-being.
Corruption by pharmaceutical companies. One would hope that this distinction would now be clear to Aftab after interviewing Cooper Davis, Executive Director of Inner Compass Initiative, who told him in 2025: We are not anti-psychiatry, anti-drug, or anti-diagnosis.
I remembered an interview with Dr. Stuart Shipko on Mad in America. In the interview he said he would not open taper centers because too many people could not come off antidepressants. My brain and my life are dependent upon a pharmaceutical company in India staying in business and manufacturing generic duloxetine until the day I die.
In this interview, he explores the philosophical foundations of psychology, the psychological costs of neoliberalism, and why developing a critical psychology of education and mental health is more urgent than ever. Listen to the audio of the interview here. The transcript below has been edited for length and clarity.
In this interview, we discuss how Open Dialogue came to be, the research that shows its positive outcomes, how psychiatry has failed to learn from Open Dialogue practice and more. Listen to the audio of the interview here. He recently published a book titled, Why Dialogue Does Cure. Nothing happened.
Editor’s note: This is an interview conducted by Tiago Pires Marques, editor of Mad in Portugal. The interview was initially conducted on February 27, 2017, and then updated recently for publication on Mad in Portugal. The interview is an abbreviated version of the interview published in Mad in Portugal (1).
Skip to main content Author Talks: Doing the heavy lifting July 17, 2025 | Interview A Wall Street Journal journalist turned bodybuilder shares how building strength helped her rebuild her life—physically, emotionally, and mentally. Skinny has a long history in marketing, in pharmaceuticals. Christine Y.
A dedicated team interviewed employees at all levels of the business on how AI might improve their work environment. A high-trust culture, modeled on credibility, respect, and fairness , is the cornerstone of that success.
Listen to the audio of the interview here. They interviewed us for four hours and brought the two main doctors up on charges. I dont know this for a fact, but Id bet a lot of money goes into The New York Times from pharmaceutical advertising. My name is Brooke Siem, and Im the author of May Cause Side Effects.
This led to significant long-term medication withdrawal that Nelson is still navigating at the time of this interview. Listen to the audio of the interview here. For example, with you right now, I can notice I have a little bit of antsy interview energy if I pay attention to my body, but I can notice that and stay engaged.
The pharmaceutical industry set out to change that mindset when they were marketing the SSRIs and SNRIs, with campaigns that told people depression was caused by a chemical imbalance. ” Article → Back to Around the Web The post Beyond the “Chemical Imbalance” Theory: An Interview With Prof.
I’d say a couple dozen interview processes of various lengths and successes. Basically anything other than pharmaceutical marketing. 25 percent and that’s being VERY generous. 60 percent and again, very generous. Searching in 2021/22 was much more fruitful. Cold-applying and nothing else.
Listen to the audio of the interview here. When medical historians say, “This particular person got an appreciable amount of money from a pharmaceutical company, in this case, Merck and Parke-Davis,” we want to know how much money it is. The transcript below has been edited for length and clarity. Cosgrove: Yes.
I n this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. Listen to the audio of the interview here. Who’s Maudsley?
From EmpowerUAmerica : “Listen in as EmpowerU host Michael Mercier interviews psychologist and author Bruce E. Levine regarding the problem of depression in America. ” Back to Around the Web The post Debunking the Myths About Depression and Antidepressants appeared first on Mad In America.
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here. Moore: The last couple of questions are related to the pharmaceutical industry. How about the kids?
Sheldon’s workplace design for global pharmaceuticals company Novo Nordisk breaks conventional workplace norms by separating two floors into a collaboration floor and a focus floor, catering to neurodiverse needs.
Interviewing founders while still raising funds, Pitts says, has given the partners “a unique sense of empathy because we know what it’s like to want to do something and not have the money to do it.… “They don’t get the same amount of money that other startups get, so they have to come up with other strategies to be successful.”
A while back, I interviewed Mung Chiang , the president of Purdue University (an institution that Fast Company has honored previously and is No. To better understand how this symbiotic relationship leads to business innovation, and to celebrate the schools where the magic is most likely to happen. 26 on Ignition Schools ‘24).
In this interview, Justin joins us to talk about the ways in which society has attempted to explain or categorize madness over the years. Listen to the audio of the interview here. Moore: And of course, it was an open door then for the pharmaceutical industry, wasn’t it, with their massive marketing dollars.
To not sell yourself short, you have to know your priorities going into an interview or conversation with your boss. Create your own boundaries from the start Gina Newton, a pharmaceutical consultant-turned-spiritual lifestyle coach, sets clear boundaries with clients up front.
Two segments, energy and manufacturing, account for much of the rising demand as companies scramble to build everything from liquefied-natural-gas facilities and pharmaceutical plants to data centers and chip fabs. Risks are rising as uncertainty grows about geopolitics, tariffs, trade , interest rates, and macroeconomic conditions.
But some people get prescription pharmaceuticals for exactly this type of thing, and I’m not a big fan of the idea that only officially sanctioned drugs are effective. You may also like: should you accept an alcoholic drink during a job interview? I’ll probably try this again, but I wanted to get a second opinion.
Maja Henderson, Office Manager at Square Hot desking in the APEC region The Singapore Newspaper – TODAY has interviewed 10 firms, 6 firms said that they would retain their present hybrid work arrangements after the Covid 19 pandemic. It makes me feel more in touch with my co-workers and what’s going on in the company.
Information interview requests from fellow alumni. I’m doing phone or in-person interviews almost every weekday which is good and promising, but nothing has stuck. but lately I’ve only been getting one in-person interview before I get the dreaded “thanks but no thanks” email. Don’t do it!
I’m not considered disabled enough for benefits (believe me, I’ve applied), and I’ve already exhausted all the pharmaceutical options available to treat my condition, to no avail. I hope you can understand, in this context, why I become burnt out on jobs really quickly. My condition is permanent and incurable.
Nail-biting and job interviews. I hate it, and worry that it will look gross or unprofessional to my interviewers. I’ve never had good luck keeping acrylic nails on, but should I try, at least for interviews? I recently had a series of interviews that resulted in a job offer.
Five years ago, I got to the third interview stage at a nonprofit. It was a healthcare-related nonprofit, and the articles indicated that the organization was funded and heavily influenced by corporate pharmaceutical companies despite portraying itself as an advocate for patients. I was one of the finalists for a decent position.
Listen to the audio of the interview here. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are.
An influential voice in bioethics, Elliott is known for his critical examination of the medical and pharmaceutical industries. In this interview, Elliott discusses the systemic issues that protect wrongdoers, the personal and professional toll on those who speak out, and the broader implications for ethics in medical research and practice.
That’s been the question posed to me in 2023 by interviewers such as Nick Fortino on “ Psychology Is ” and Mollie Adler on “Back from the Borderline. ” The psychiatric-pharmaceutical-industrial complex is fueled by the profits of Big Pharma, which have made a staggering amount of money from psychiatric drugs.
Listen to the audio of the interview here. Siem: You don’t serve the pharmaceutical company who might be paying you on the side. I was recently interviewing Robert Haim Belmaker and Pesach Lichtenberg. The transcript below has been edited for length and clarity. Can you tell us how you ended up in the field?
In this interview, Kleinman explores critical issues facing modern healthcare. Listen to the audio of the interview here. The middle class has come to understand genetics, biotechnology, and pharmaceuticals and is better educated in science and technology. See prior interview with Mad in America.)
Listen to the audio of the interview here. But society then became fully entrenched in the idea that mental health is a genetic or a chemical imbalance, which worked too well for pharmaceutical marketing. To donate, visit: [link] donate/ The post The Anatomy of Anxiety: An Interview With Ellen Vora appeared first on Mad In America.
Listen to the audio of the interview here. When you’re working with a client who has latched onto a metaphor, like the “broken brain” metaphor — which holds considerable cultural sway and is often endorsed by the psychiatric establishment and even pharmaceutical companies — how do you approach it?
In this interview, we talk about her experiences of withdrawal from a cocktail of psychiatric drugs and her debut memoir, May Cause Side Effects , published in 2022 which is one of the first books on antidepressant withdrawal to make it to the mass market. Listen to the audio of the interview here. James Moore: Brooke, welcome.
I surprised myself at how much I enjoyed the experience of interviewing these interesting patients. Medical research is largely funded by the pharmaceutical industry, papers ghostwritten by the pharmaceutical industry and influencers paid by the pharmaceutical industry.
2024 Around-America Tour For almost two decades, my “True Crime” story has, sadly, been my unique contribution to challenging the powerful influence that the pharmaceutical industry has on the global healthcare system. Our family tragedy also provided the basis for the CTV W5 episodes Over the Edge (2007) and The Problem with Pills (2021).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content